These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38582869)

  • 1. Impact of risk factors, early rehabilitation and management of lymphedema associated with breast cancer: a retrospective study of breast Cancer survivors over 5 years.
    Tomić S; Malenković G; Mujičić E; Šljivo A; Tomić SD
    BMC Womens Health; 2024 Apr; 24(1):226. PubMed ID: 38582869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.
    Jia M; Pan L; Yang H; Gao J; Guo F
    Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining breast cancer-related lymphedema (BCRL) prevalence and risk factors: A pragmatic approach to lymphedema surveillance.
    Hing JX; Chua YN; Tan PT; Tan MSL; Mok CW; Seet MYL; Lin ZC; Seah CM; Lee WP; Tan SM
    Ann Acad Med Singap; 2024 Feb; 53(2):80-89. PubMed ID: 38920232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
    Rebegea L; Firescu D; Dumitru M; Anghel R
    Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
    Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
    Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer - a long-term observation.
    Rupp J; Hadamitzky C; Henkenberens C; Christiansen H; Steinmann D; Bruns F
    Radiat Oncol; 2019 Mar; 14(1):39. PubMed ID: 30845971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
    Lim SM; Han Y; Kim SI; Park HS
    BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manual lymphatic drainage for lymphedema following breast cancer treatment.
    Ezzo J; Manheimer E; McNeely ML; Howell DM; Weiss R; Johansson KI; Bao T; Bily L; Tuppo CM; Williams AF; Karadibak D
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD003475. PubMed ID: 25994425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of breast cancer-related lymphedema in Korea: a nationwide retrospective cohort study.
    Ahn HR; Jeong HE; Jeong C; Kang SY; Jung SH; Youn HJ; Kim JS
    Int J Surg; 2024 Jun; 110(6):3518-3526. PubMed ID: 38477155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving quality of life after breast cancer: a comparison of two microsurgical treatment options for breast cancer-related lymphedema (BCRL).
    Seidenstuecker K; Fertsch S; Ghazaleh AA; Fabi A; Stoffel J; Bukowiecki J; Wolter A; Aghlmandi S; Nadella A; Halbeisen FS; Andree C; Haug MD; Schaefer DJ; Handschin TM; Kappos EA
    Clin Exp Med; 2024 Apr; 24(1):82. PubMed ID: 38653874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the Risk Factors of Breast Cancer-Related Lymphedema and Construction and Evaluation of a Prediction Model.
    Li H; Li WB; Sun ZX; Yu J; Lv PY; Li CX; Liang X; Yu Y; Zhao ZB
    Lymphat Res Biol; 2023 Dec; 21(6):565-573. PubMed ID: 37768813
    [No Abstract]   [Full Text] [Related]  

  • 13. Time trend of breast cancer-related lymphedema according to body mass index.
    Ogiya A; Kimura K; Ueno T; Iwase T; Ohno S
    Eur J Surg Oncol; 2024 Jun; 50(6):108350. PubMed ID: 38653160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
    Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
    J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 4-Year Institutional Experience of Immediate Lymphatic Reconstruction.
    Granoff MD; Fleishman A; Shillue K; Johnson AR; Ross J; Lee BT; Teller P; James TA; Singhal D
    Plast Reconstr Surg; 2023 Nov; 152(5):773e-778e. PubMed ID: 36877759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of Lymphedema in Women with Breast Cancer: a Case Control Study in Shiraz, Southern Iran.
    Honarvar B; Sayar N; Tahmasebi S; Zakeri Z; Talei A; Rostami S; Khademi S; Sabzi Sarvestani A; Sekhavati E
    Asian Pac J Cancer Prev; 2016; 17(S3):81-6. PubMed ID: 27165213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the prevention and treatment of breast cancer-related lymphedema.
    Donahue PMC; MacKenzie A; Filipovic A; Koelmeyer L
    Breast Cancer Res Treat; 2023 Jul; 200(1):1-14. PubMed ID: 37103598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
    Herremans KM; Cribbin MP; Riner AN; Neal DW; Hollen TL; Clevenger P; Munoz D; Blewett S; Giap F; Okunieff PG; Mendenhall NP; Bradley JA; Mendenhall WM; Mailhot-Vega RB; Brooks E; Daily KC; Heldermon CD; Marshall JK; Hanna MW; Leyngold MM; Virk SS; Shaw CM; Spiguel LR
    Ann Surg Oncol; 2021 Oct; 28(10):5775-5787. PubMed ID: 34365563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining reconstructive and ablative surgical treatment of chronic breast cancer-related lymphedema (BCRL): safe and effective.
    Ghazaleh AA; Handschin TM; Buckowiecki J; Chammartin FS; Andree C; Schaefer DJ; Haug M; Kappos EA; Seidenstuecker K
    Breast Cancer Res Treat; 2023 Jan; 197(1):83-92. PubMed ID: 36287309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical-Site Infection is Associated With Increased Risk of Breast Cancer-Related Lymphedema: A Nationwide Cohort Study.
    Jørgensen MG; Gözeri E; Petersen TG; Sørensen JA
    Clin Breast Cancer; 2023 Jul; 23(5):e296-e304.e2. PubMed ID: 37095025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.